Insights

Australia's biggest independent wealth manager, Perpetual, has shaken up its senior equities investment team, with the veteran Charlie Lanchester to depart.

Australia's trade balance fell into the red in July, but it should bounce into the black in coming months as resource exports increase.

There have been many policies and legislation coming out of Canberra that fit into the category of "it seemed like a good idea at the time". Unfortunately, superannuation seems to have had more than its fair share of them.

Australia's public health system is costly and in dire need of reform. A funding overhaul that shifts financial responsibility from the bloated public sector bureaucracy to the individual is one solution.

Maurice Newman's review of Newcrest Mining's investor relations conduct shows that continuous disclosure only works as intended if the market understands what information is being disclosed.

Local market falls as traders take short-term profits in materials stocks.

Federal Court dismisses dispute with ATO about offshore banking unit's tax rate.

As Australia's wealth management industry shrinks further, investors should hone their radar for any conflict of interest.

The ALP's campaign on the Coalition's 'budget black hole' has failed to consume voters. That's why Joe Hockey offered little extra to the electorate today.

Moody's warns GFC shows govts can bail out creditors selectively.

Maurice Newman agrees with Don Mercer. Newcrest has done nothing wrong.

Shares are weaker after a surprise trade deficit cemented downward pressure, adding to concern over lower credit ratings on some of Australia's "big four" bank debt offerings.

Coalition cuts announced today will make little difference to the flat economic landscape Tony Abbott is likely to face in office.

A new university study suggests that we may be wasting time and money trying to clean up fossil fuels through carbon capture and storage because renewables will be cheaper and as reliable.

Local market weakens as Australian trade balance swings to a deficit.

The syringe developer plummeted today after a news article questioned the company's credibility.